Why Johnson & Johnson (JNJ) is Back on Investors’ Radar Johnson & Johnson (JNJ) has drawn fresh attention after recent ...
JNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures.
Johnson & Johnson (NYSE:JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per ...
Zacks Investment Research on MSN
Why Johnson & Johnson (JNJ) is a top dividend stock for your portfolio
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is ...
Zacks Investment Research on MSN
Johnson & Johnson (JNJ) beats stock market upswing: What investors need to know
Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.16%. On the other hand, the Dow ...
Johnson & Johnson reports Q4 earnings Jan 21 with 22% EPS growth expected. Stelara biosimilars and talc verdict weigh on ...
If you are wondering whether Johnson & Johnson is reasonably priced at its recent levels, you are not alone. Many investors ...
J&J beat Wall Street estimates on sales and profits in the third quarter. The company recently announced the acquisition of a biotech with an innovative cancer treatment. 10 stocks we like better than ...
Johnson & Johnson’s post-Kenvue shift boosts growth and free cash flow, with an elite balance sheet but mixed revisions.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results